HYPERACTIVITY IN CHILDREN WITH DOWN SYNDROME

Clinical trials for HYPERACTIVITY IN CHILDREN WITH DOWN SYNDROME explained in plain language.

Never miss a new study

Get alerted when new HYPERACTIVITY IN CHILDREN WITH DOWN SYNDROME trials appear

Sign up with your email to follow new studies for HYPERACTIVITY IN CHILDREN WITH DOWN SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Hyperactivity drug trial for kids with down syndrome ends early

Symptom relief Terminated

This study aimed to see if the drug guanfacine could reduce hyperactivity and impulsivity in children aged 6 to 12 with Down syndrome. Only 3 children enrolled before the study was stopped early. The main goal was to measure changes in hyperactivity scores after 8 weeks of treatm…

Matched conditions: HYPERACTIVITY IN CHILDREN WITH DOWN SYNDROME

Phase: PHASE2 • Sponsor: Rachel G. Greenberg, MD, MB, MHS • Aim: Symptom relief

Last updated May 14, 2026 12:03 UTC

HYPERACTIVITY IN CHILDREN WITH DOWN SYNDROME

Get alerted when new HYPERACTIVITY IN CHILDREN WITH DOWN SYNDROME trials appear

Hyperactivity drug trial for kids with down syndrome ends early